Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from vaccine supply and licensing deals such as with Japan's Takeda Pharmaceuticals.

Novavax (($NVAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Novavax’s Q3 2025 Earnings Call: A Cautiously ...

Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can also ...

Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 as the biotech awaits key product launches from its partnership with ...

AVGO has pulled back slightly after tapping its record in September Almost one month into the final quarter of 2025, Wall Street has seen no shortage of volatility thanks to U.S.-China trade talks, ...

The Week 7 afternoon slate was one to remember. Headlining the slate was an NFC East rivalry matchup as the Washington Commanders visited the Dallas Cowboys in one of the NFL's oldest rivalries.

It looked like the Charlotte Hornets were going to finally get the monkey off their back, that is the Philadelphia 76ers, but they blew a double-digit lead late in the fourth quarter, ultimately ...